To Refer or Not to Refer: Factors that Affect Primary Care Provider Referral of Patients with Cancer to Clinical Treatment Trials

Journal of Cancer Education

Volumn 19, Issue 1, 2004, Pages 58-65

  Sherwood, Paula R ^a   Given, Barbara A ^a   Scholnik, Aaron ^b   Given, Charles W ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MSU s Center for Bioethics and Social Justice   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER; CANCER RESEARCH; DECISION MAKING; FEMALE; FINANCIAL MANAGEMENT; HEALTH CARE PERSONNEL; HUMAN; MALE; MEDICAL EDUCATION; NORMAL HUMAN; PATIENT REFERRAL; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW;

EID: 2142696494     PISSN: 08858195     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15430154jce1901_13     Document Type: Review

References (16)

1. American Cancer Society. Encouraging Participation in Clinical Trials. ACS News Today. Available at: http://www.cancer.org/docroot/NWS/content/ NWS_1_1x_Encouraging_Participation_in_Clinical_Trials_.asp. Accessed December 20, 2002.
2. Llewellyn-Thomas H, McGreal J, Thiel E. Cancer patients' decision making and trial-entry preferences: The effects of "framing" information about short-term toxicity and long-term survival. Med Decis Making. 1995;15:4-12.
3. Ellis P. Attitudes towards and participation in randomized clinical trials in oncology: a review of the literature. Ann Oncol. 2000;11:939-945.
4. Fallowfield L, Jenkins V, Brennan C, et al. Attitudes of patients to randomized clinical trials of cancer therapy. Eur J Cancer. 1998;34:1554-1559.
5. Finn R. Surveys identify barriers to participation in clinical trials. J Natl Cancer Inst. 2000;92:1556-1558.
6. Harris Interactive. Many reasons why people are reluctant to participate in clinical trials. Available at: http://www.harrisinteractive.com/news/allnewsbydate.asp?NewsID=439. Accessed May 9, 2002.
7. Jenkins V, Fallowfield L. Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy. Br J Cancer. 2000;82:1783-1788.
8. Ellis P, Dowsett S, Butow P, et al. Attitudes to randomized clinical trials amongst out-patients attending a medical oncology clinic. Health Expect. 1999;2:33-43.
9. Kinney A, Richards C, Vernon S, et al. The effect of physician recommendation on enrollment in the breast cancer chemoprevention trial. Prev Med. 1998;27:713-719.
10. Ellis P, Hobbs M, Rikard-Bell G, et al. General practitioners' attitudes to randomized clinical trials for women with breast cancer. Med J Aust. 1999;171:303-305.
11. Crosson K, Eisner E, Brown C, et al. Primary care physician's attitudes, knowledge, and practices related to cancer clinical trials. J Cancer Educ. 2001;16:188-192.
12. Siminoff L, Zhang A, Colabianchi N, et al. Factors that predict the referral of breast cancer patients onto clinical trials by their surgeons and medical oncologists. J Clin Oncol. 2000;18:1203-1211.
13. Mansour E. Barriers to clinical trials. Cancer. 1994;74 (suppl):2672-2675.
14. Trabert E. Strategies to increase patient enrollment in clinical trials. Oncol Roundtable. 1999;13:1-15.
15. McCaskill-Stevens W, Pinto H, Marcus A, et al. Recruiting minority cancer patients into cancer clinical trials: a pilot project involving the Eastern Cooperative Oncology Group and the National Medical Association. J Clin Oncol. 1999;17:1029-1039.
16. Dillman D. Mail and internet surveys: The tailored design method. New York, NY: John Wiley & Sons; 1999.